Navigation Links
Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial
Date:10/6/2008

- TARGIT Procedure May Eliminate 6 Weeks of Radiation Therapy - Event: Watch Single-Dose Radiation Treatment over the Internet Wednesday, October 22, 2008, 3 - 4 p.m. by visiting http://www.sentara.com/explorehealth

HAMPTON, Va., Oct. 6 /PRNewswire/ - Questions raced through Vela Cross' mind when she was diagnosed with breast cancer in May. Would she have the tumor removed or her entire breast? How about radiation or chemotherapy?

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/sentara/35294/

With doctors at Sentara CarePlex Hospital involved in the international TARGIT Trial, Cross became the first East Coast patient to receive this revolutionary treatment option.

Sentara CarePlex Hospital in Hampton, Virginia is among five U.S. centers and 22 worldwide enrolling patients in this study open to early-stage breast cancer patients. The study evaluates the effectiveness of an investigational single-dose internal radiation treatment compared with conventional external radiation.

The TARGIT Trial, which stands for TARGeted Intraoperative-radiation Therapy, could eliminate the need for six weeks of daily radiation.

"Regular radiation would have really interrupted my life," says Cross.

"Some women consider a mastectomy rather than facing weeks of conventional radiation," says surgical oncologist Dr. Richard Hoefer. "We hope our participation offers women another option," he continues.

Half of trial participants get the investigational one-time dose of radiation through an applicator placed in the tumor cavity. The radiation is targeted to breast cells with the highest risk of cancer recurrence-those that directly surrounded the tumor. Other trial participants receive 6-8 weeks of external radiation.

Equipment involved in this study was cleared by the U.S. FDA as safe and effective; trials at Sentara are subject to rigorous approvals.

"This study could significantly change the way we care for early-stage breast cancer patients," says Dr. Michael Miller, medical director of CarePlex Hospital's radiation oncology department.

TARGIT is a randomized phase III study, enrolling post-menopausal women at least 45 years old with single-site invasive breast cancer measuring less than 3 centimeters. For a patient to receive the single-dose radiation, they must be a candidate for the TARGIT Trial. Other considerations include type of cancer, tumor size, and lymph node involvement. To learn more, call 757-594- 1939 or visit http://www.sentara.com/cancer.


'/>"/>
SOURCE Sentara CarePlex Hospital
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
3. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
4. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
5. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
6. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
9. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
10. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
11. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... SPRING, Md. , Dec. 2, 2016 ... new indication for Jardiance (empagliflozin) to reduce the risk ... diabetes mellitus and cardiovascular disease. "Cardiovascular ... with type 2 diabetes mellitus," said Jean-Marc Guettier ... and Endocrinology Products in FDA,s Center for Drug Evaluation ...
(Date:12/2/2016)... , December 2, 2016 ... global cardiac pacemaker market in its upcoming report titled, "Global Market Study ... a Declining CAGR of -1.4% between 2016 and 2024". The ... Mn in 2015 and this is likely to decline ... revenue, the global cardiac pacemaker market is anticipated to ...
(Date:12/2/2016)... , December 2, 2016 According to ... "Global Market Study on Automated Endoscope Reprocessors: Single Basin Automated ... of 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors ... expected to expand at a CAGR of 7.2% during an ... US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest ... patients, standing as living proof that attitude and determination can combine into the ... that spike around the holidays. This campaign will offer patients a new-found hope, ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd ... Beach Resort and Spa in Honolulu, offering local frontline clinicians the opportunity to ... , The demand for supplemental training related to pain management has surged ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 ... to create versatile lower third titles with just a few clicks of the mouse," ... 2 includes 30 lower third animations. Choose from various styles with accented animations, rigid ...
(Date:12/2/2016)... Miami, FL (PRWEB) , ... December 02, 2016 , ... ... they are winners of $1,000 each from the National Family Partnership and the Drug ... winning families who decorated their homes and the 10 winning schools who decorated their ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... treatment has announced the opening of a new eating disorder treatment center location ... outpatient treatment for adults and adolescents, both males and females ages 10 and ...
Breaking Medicine News(10 mins):